- Home
- SCOR vs GDTC Comparison
SCOR vs GDTC Comparison
Compare SCOR & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCOR
- GDTC
- Stock Information
- Founded
- SCOR 1999
- GDTC 2018
- Country
- SCOR United States
- GDTC Singapore
- Employees
- SCOR N/A
- GDTC N/A
- Industry
- SCOR Business Services
- GDTC Biotechnology: Pharmaceutical Preparations
- Sector
- SCOR Consumer Discretionary
- GDTC Health Care
- Exchange
- SCOR Nasdaq
- GDTC Nasdaq
- Market Cap
- SCOR 27.7M
- GDTC 28.0M
- IPO Year
- SCOR 2007
- GDTC 2023
- Fundamental
- Price
- SCOR $5.50
- GDTC $2.35
- Analyst Decision
- SCOR Buy
- GDTC Buy
- Analyst Count
- SCOR 2
- GDTC 1
- Target Price
- SCOR $10.75
- GDTC $5.00
- AVG Volume (30 Days)
- SCOR 8.8K
- GDTC 32.8K
- Earning Date
- SCOR 05-06-2025
- GDTC 01-01-0001
- Dividend Yield
- SCOR N/A
- GDTC N/A
- EPS Growth
- SCOR N/A
- GDTC N/A
- EPS
- SCOR N/A
- GDTC N/A
- Revenue
- SCOR $356,047,000.00
- GDTC $330,254.00
- Revenue This Year
- SCOR $4.38
- GDTC $14.71
- Revenue Next Year
- SCOR $3.97
- GDTC N/A
- P/E Ratio
- SCOR N/A
- GDTC N/A
- Revenue Growth
- SCOR N/A
- GDTC N/A
- 52 Week Low
- SCOR $4.59
- GDTC $1.20
- 52 Week High
- SCOR $15.69
- GDTC $4.05
- Technical
- Relative Strength Index (RSI)
- SCOR 46.17
- GDTC 46.55
- Support Level
- SCOR $4.59
- GDTC $2.20
- Resistance Level
- SCOR $5.63
- GDTC $2.50
- Average True Range (ATR)
- SCOR 0.61
- GDTC 0.20
- MACD
- SCOR -0.01
- GDTC 0.00
- Stochastic Oscillator
- SCOR 53.22
- GDTC 27.54
About SCOR comScore Inc.
comScore Inc is a United States-based information and analytics company that measures advertising, content, and the consumer audiences of each across media platforms. The platforms it measures include televisions, mobile devices, computers, tablets, CTV devices, and movie theaters. The company generates almost all its revenue from the United States, followed by Europe, Latin America, Canada, and other regions. It provides solutions for the automotive, digital media, financial services, pharmaceutical, retail, technology, travel, and other industries.
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.